NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/22/2026
Back to search
Official data from USPTO
FXM RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FXM RESEARCH
ST13
US500000088776486Class
42
Filing
88776486
Registration
6135382
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
01/23/2026
Trademark type
Word
Nice classes
42
Filing date
01/28/2020
Registration date
08/25/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/22/2026
Last transaction
01/23/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
06/01/2000
First use in commerce
07/17/2001
Drawing code
4
Owner type
16
Owner location
Miami, FL
Examiner
BENMAMAN, ALICE
Current location
Historical data usage
Holders and representatives
Holders
FXM Clinical Research Miami, LLC
Representatives
Erik Lichter THE LICHTER LAW GROUP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific researchconducting clinical trials for others; Medical laboratory services; Medical research; Medical research services in the field of cancer; Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Quality evaluation services for the medical and anesthesia industries; Research and development in the field of pharmaceutical products; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific investigations for medical purposes; Scientific research; Scientific research and development
Publications
History of USPTO decisions and trademark events.
21 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/22/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/22/2026
E815
TEAS SECTION 8 & 15 RECEIVED
10/16/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/25/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/25/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE
07/09/2020
APET
ASSIGNED TO PETITION STAFF
07/08/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
06/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/09/2020
PUBO
PUBLISHED FOR OPPOSITION
06/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/20/2020
ALIE
ASSIGNED TO LIE
05/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/23/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/23/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/23/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/23/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/23/2020
DOCK
ASSIGNED TO EXAMINER
04/16/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2020
NWAP
NEW APPLICATION ENTERED
01/31/2020
Continuous trademark protection
Get notified about every new filing that threatens FXM RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.